What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Disease
The scientist’s investigation covers issues in Immunology, Transplantation, Hematopoietic stem cell transplantation, Internal medicine and Surgery.
His Immunology study incorporates themes from Haematopoiesis, Stem cell and Genetic enhancement, Suicide gene.
His study in Transplantation is interdisciplinary in nature, drawing from both Survival rate, Human leukocyte antigen, Immune system and Risk factor.
His work deals with themes such as Myeloid, Cyclophosphamide, Graft-versus-host disease, Transplantation Conditioning and Bone marrow, which intersect with Hematopoietic stem cell transplantation.
His research brings together the fields of Oncology and Internal medicine.
His Surgery research includes themes of Gastroenterology, Muscle biopsy and Clinical trial.
His most cited work include:
- Retinoic acid and arsenic trioxide for acute promyelocytic leukemia (834 citations)
- Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency (814 citations)
- Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. (805 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Immunology and Oncology.
His Internal medicine research integrates issues from Gastroenterology and Surgery.
His Transplantation research also works with subjects such as
- Leukemia that connect with fields like Myeloid,
- Stem cell and related Cancer research and Genetic enhancement.
His Hematopoietic stem cell transplantation research focuses on Fludarabine and how it connects with ThioTEPA and Busulfan.
His studies in Immunology integrate themes in fields like Haematopoiesis and Suicide gene.
His Oncology study combines topics in areas such as Treosulfan and Minimal residual disease.
He most often published in these fields:
- Internal medicine (54.49%)
- Transplantation (44.89%)
- Hematopoietic stem cell transplantation (35.29%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (54.49%)
- Transplantation (44.89%)
- Coronavirus disease 2019 (4.61%)
In recent papers he was focusing on the following fields of study:
Fabio Ciceri focuses on Internal medicine, Transplantation, Coronavirus disease 2019, Oncology and Gastroenterology.
His Cyclophosphamide, Acute leukemia, Myeloid leukemia, Incidence and Pneumonia study are his primary interests in Internal medicine.
Fabio Ciceri combines subjects such as Human leukocyte antigen and Bone marrow with his study of Cyclophosphamide.
His study in Hematopoietic stem cell transplantation and Graft-versus-host disease falls within the category of Transplantation.
Fabio Ciceri studied Coronavirus disease 2019 and 2019-20 coronavirus outbreak that intersect with Betacoronavirus and Immunology.
His biological study spans a wide range of topics, including Hematopoietic cell, Prospective cohort study, Leukemia, Post transplant cyclophosphamide and Treosulfan.
Between 2019 and 2021, his most popular works were:
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19. (503 citations)
- Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. (436 citations)
- Complement as a target in COVID-19? (233 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
The scientist’s investigation covers issues in Internal medicine, Coronavirus disease 2019, Pneumonia, Disease and Transplantation.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Oncology.
His research in Pneumonia intersects with topics in Diabetes mellitus, Asymptomatic, ARDS and Immunology.
His research integrates issues of Cell and Efficacy in his study of Immunology.
Fabio Ciceri studies Transplantation, focusing on Graft-versus-host disease in particular.
The study incorporates disciplines such as Hematopoietic stem cell transplantation, Haematopoiesis, Maintenance therapy and Marrow transplantation in addition to Acute leukemia.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
